PS
PRPH

Principal Securities’s ProPhase Labs PRPH Stock Holding History

Principal Securities’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$3.91K – 3822
2025
Q2 		$3.91K Buy
+1,000
New +$3.35K ﹤0.01% 2936

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Securities's PRPH Position: Q3 2025 in Review

Principal Securities sold out of ProPhase Labs (PRPH) in Q3 2025, closing a stake of 1,000 shares — an estimated $3.91K sold.

Principal Securities first reported a position in PRPH in Q2 2025 and held it in 1 quarter. The position peaked at $3.91K in Q2 2025. 28 funds tracked by Wall St. Rank hold PRPH as of Q3 2025.

  • Principal Securities reported no remaining ProPhase Labs position as of Q3 2025 after selling out during the quarter.
  • Principal Securities sold 1,000 ProPhase Labs shares in Q3 2025, an estimated $3.91K.
  • Principal Securities first reported a position in ProPhase Labs in Q2 2025 and held it in 1 quarter.
  • Principal Securities's ProPhase Labs position peaked at $3.91K in Q2 2025.
  • 28 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2025.

Based on Principal Securities's 13F filing for Q3 2025, filed 12 Nov 2025.